Last reviewed · How we verify

NCT04806802

APIOC Sphere and APIOC Astigmatism

Completed NA Last updated 19 January 2022
What this trial tests

NA trial testing APIOC Sphere and APIOC Astigmatism in Myopia in 50 participants. Completed in 31 October 2021.

Timeline
18 March 2021
Primary endpoint
31 October 2021
31 October 2021

Quick facts

Lead sponsorLentechs, LLC
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment50
Start date18 March 2021
Primary completion31 October 2021
Estimated completion31 October 2021
Sites6 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Lentechs, LLC

Who can join

Adults 18 to 35, any sex, with Myopia or Hyperopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vision and comfort, both objective and subjective, will be assessed for single vision contact lens wearers for either the APIOC™ Sphere or the APIOC™ Astigmatism contact lenses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Lentechs, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04806802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing